These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33320246)

  • 1. Regulation of ST6GAL1 sialyltransferase expression in cancer cells.
    Dorsett KA; Marciel MP; Hwang J; Ankenbauer KE; Bhalerao N; Bellis SL
    Glycobiology; 2021 Jun; 31(5):530-539. PubMed ID: 33320246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism.
    Jones RB; Silva AD; Ankenbauer KE; Britain CM; Chakraborty A; Brown JA; Ballinger SW; Bellis SL
    Glycobiology; 2023 Oct; 33(8):626-636. PubMed ID: 37364046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.
    Wichert B; Milde-Langosch K; Galatenko V; Schmalfeldt B; Oliveira-Ferrer L
    Glycobiology; 2018 Nov; 28(11):898-903. PubMed ID: 30016515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness.
    Hait NC; Maiti A; Wu R; Andersen VL; Hsu CC; Wu Y; Chapla DG; Takabe K; Rusiniak ME; Bshara W; Zhang J; Moremen KW; Lau JTY
    Cancer Gene Ther; 2022 Nov; 29(11):1662-1675. PubMed ID: 35676533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of ST6GAL1 in human bladder cancer.
    Antony P; Rose M; Heidenreich A; Knüchel R; Gaisa NT; Dahl E
    BMC Cancer; 2014 Dec; 14():901. PubMed ID: 25465919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
    Dorsett KA; Jones RB; Ankenbauer KE; Hjelmeland AB; Bellis SL
    J Ovarian Res; 2019 Oct; 12(1):93. PubMed ID: 31610800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
    Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
    J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease.
    Krick S; Helton ES; Easter M; Bollenbecker S; Denson R; Zaharias R; Cochran P; Vang S; Harris E; Wells JM; Barnes JW
    Front Immunol; 2021; 12():693149. PubMed ID: 34290711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
    Souady J; Hülsewig M; Distler U; Haier J; Denz A; Pilarsky C; Senninger N; Dreisewerd K; Peter-Katalinic J; Müthing J
    Glycobiology; 2011 May; 21(5):584-94. PubMed ID: 21147760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ST6GAL1 in the tumor progression of colorectal cancer.
    Zhang S; Lu J; Xu Z; Zou X; Sun X; Xu Y; Shan A; Lu J; Yan X; Cui Y; Yan W; Du Y; Gu J; Zheng M; Feng B; Zhang Y
    Biochem Biophys Res Commun; 2017 May; 486(4):1090-1096. PubMed ID: 28377225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
    Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
    Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
    Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
    J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.
    Bhalerao N; Chakraborty A; Marciel MP; Hwang J; Britain CM; Silva AD; Eltoum IE; Jones RB; Alexander KL; Smythies LE; Smith PD; Crossman DK; Crowley MR; Shin B; Harrington LE; Yan Z; Bethea MM; Hunter CS; Klug CA; Buchsbaum DJ; Bellis SL
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37643018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types.
    Venturi G; Gomes Ferreira I; Pucci M; Ferracin M; Malagolini N; Chiricolo M; Dall'Olio F
    Glycobiology; 2019 Sep; 29(10):684-695. PubMed ID: 31317190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Inhibitory Role of α2,6-Sialylation in Adipogenesis.
    Kaburagi T; Kizuka Y; Kitazume S; Taniguchi N
    J Biol Chem; 2017 Feb; 292(6):2278-2286. PubMed ID: 28031460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
    Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
    Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the ST6 β-galactosamide α-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2/cell adhesion molecule 1 and enhancement of ErbB2/ErbB3 signaling by microRNA-199a.
    Minami A; Shimono Y; Mizutani K; Nobutani K; Momose K; Azuma T; Takai Y
    J Biol Chem; 2013 Apr; 288(17):11845-53. PubMed ID: 23504322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
    Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
    EBioMedicine; 2024 Jun; 104():105163. PubMed ID: 38772281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST6Gal1: Oncogenic signaling pathways and targets.
    Gc S; Bellis SL; Hjelmeland AB
    Front Mol Biosci; 2022; 9():962908. PubMed ID: 36106023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.